The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Biotech stock Corvus Pharmaceuticals catapulted to an eight-year high Tuesday on promising results in eczema treatment.

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

This session examines Saudi Arabia’s value proposition as a regional manufacturing hub for healthcare and medical ...

The discussion focuses on how KAIMRC integrates clinical research, biobanking, data infrastructure, and translational science ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice.

The real estate investment trust sold off hundreds of millions of dollars worth of medical buildings to fund its latest ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.